Skip to main content
中科美菱 logo

中科美菱 — Investor Relations & Filings

Ticker · 920992 Beijing Stock Exchange Manufacturing
Filings indexed 437 across all filing types
Latest filing 2024-01-17 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920992

About 中科美菱

http://www.zkmeiling.com/

Zhongke Meiling Cryogenics Co., Ltd., branded as Meling Biology & Medical, specializes in the research, development, and manufacturing of low-temperature storage solutions and laboratory equipment. The product portfolio includes ultra-low temperature freezers capable of reaching -86°C and -164°C, medical refrigerators, blood bank refrigerators, and pharmacy refrigerators. The company also provides cold chain logistics equipment and biological sample bank management systems. Its technical focus centers on advanced cryogenic cooling systems designed for the preservation of biological materials, vaccines, and medical supplies. These solutions are utilized by research institutes, healthcare facilities, and pharmaceutical organizations requiring precise temperature control and long-term storage reliability.

Recent filings

Filing Released Lang Actions
关于使用部分闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from a company about the progress of using idle raised funds for cash management, specifically investing in bank structured deposits. It includes specifics about the investment products, amounts, expected returns, risk controls, and internal oversight. The document is not a full financial report like an Annual Report or Interim Report, nor is it a brief announcement of a report publication. It is a regulatory announcement about capital management activities related to fundraising proceeds. This fits best under Capital/Financing Update (CAP) as it updates on the company's use of raised funds and related financial activities.
2024-01-17 Chinese
关于使用自有闲置资金购买理财产品的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's use of its own idle funds to purchase financial products, specifically bank wealth management products. It includes details about the investment amount, expected returns, risk disclosures, and internal controls related to these financial products. The document is a progress announcement about capital management activities rather than a financial report or earnings release. It does not contain financial statements or detailed financial performance data. The document length is relatively short (2276 characters) and focuses on a specific capital/financing update. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-01-15 Chinese
公司章程
Governance Information Classification · 95% confidence The document is a detailed company charter or articles of association for Zhongkemeiling Cryogenics Co., Ltd., covering company governance, shareholder rights, board structure, share issuance, shareholder meetings, and related corporate governance matters. It includes detailed provisions on shareholder meetings, voting, board and management roles, share issuance and transfer, and other governance rules. There is no indication that this is an annual report, financial report, earnings release, or any other financial disclosure. Instead, it is a governance document outlining the company's internal rules and structure. Therefore, the document best fits the category of Governance Information (CGR). The document length (15,000 characters) and content confirm it is the full governance document, not just an announcement or summary.
2023-12-27 Chinese
关联交易管理制度
Governance Information Classification · 95% confidence The document is titled as a management system for related party transactions of the company 中科美菱低温科技股份有限公司. It details the definitions, procedures, and rules regarding related party transactions, including decision-making processes, disclosure requirements, and board and shareholder meeting roles. It is a governance-related document outlining internal policies and compliance with regulatory requirements. There is no financial data, no report of financial results, no announcement of voting results, no executive changes, no earnings data, no legal proceedings, no capital changes, and no mention of report publication. The document is a formal governance policy issued by the board and approved by the shareholders, consistent with governance information filings. Therefore, the appropriate classification is Governance Information (CGR). The document length is 4539 characters, which is substantive and not a mere announcement or certification, supporting this classification with high confidence.
2023-12-27 Chinese
募集资金管理制度
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of the company's '募集资金管理制度' (Fundraising Capital Management System), including rules and procedures for managing and using raised funds. It includes sections on fund storage, usage, changes in usage, and supervision. The document is a formal policy or system announcement rather than a financial report or earnings release. It is not a report of financial results, audit, or management discussion. It is also not a short announcement of a report publication but a substantive governance-related document. The content aligns best with a Regulatory Filing (RNS) as it is a compliance and procedural disclosure related to fundraising management, without financial statements or earnings data. The document length is under 5,000 characters, but it contains the full text of the management system, not just a notice of publication, so it is not RPA. Therefore, the best classification is Regulatory Filings (RNS).
2023-12-27 Chinese
独立董事制度
Governance Information Classification · 95% confidence The document is a detailed announcement of the company's Independent Director System, including qualifications, nomination, rights, duties, and procedures related to independent directors. It references a shareholders meeting held on December 28, 2023, where revisions to the Independent Director System were approved. The content is regulatory and governance-related, focusing on internal rules and governance practices rather than financial data or report publication. It is not a financial report, earnings release, or audit report. It is not a simple announcement of voting results or a proxy solicitation. The document fits best under Governance Information (CGR) as it details the company's governance structure and practices regarding independent directors.
2023-12-27 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.